Literature DB >> 10430750

CD8+ve cells in the lungs of smokers with chronic obstructive pulmonary disease.

M Saetta1, S Baraldo, L Corbino, G Turato, F Braccioni, F Rea, G Cavallesco, G Tropeano, C E Mapp, P Maestrelli, A Ciaccia, L M Fabbri.   

Abstract

Previous studies have shown an increased number of inflammatory cells and, in particular, CD8+ve cells in the airways of smokers with chronic obstructive pulmonary disease (COPD). In this study we investigated whether a similar inflammatory process is also present in the lungs, and particularly in lung parenchyma and pulmonary arteries. We examined surgical specimens from three groups of subjects undergoing lung resection for localized pulmonary lesions: nonsmokers (n = 8), asymptomatic smokers with normal lung function (n = 6), and smokers with COPD (n = 10). Alveolar walls and pulmonary arteries were examined with immunohistochemical methods to identify neutrophils, eosinophils, mast cells, macrophages, and CD4+ve and CD8+ve cells. Smokers with COPD had an increased number of CD8+ve cells in both lung parenchyma (p < 0.05) and pulmonary arteries (p < 0.001) as compared with nonsmokers. CD8+ve cells were also increased in pulmonary arteries of smokers with COPD as compared with smokers with normal lung function (p < 0.01). Other inflammatory cells were no different among the three groups. The number of CD8+ve cells in both lung parenchyma and pulmonary arteries was significantly correlated with the degree of airflow limitation in smokers. These results show that an inflammatory process similar to that present in the conducting airways is also present in lung parenchyma and pulmonary arteries of smokers with COPD.

Entities:  

Mesh:

Year:  1999        PMID: 10430750     DOI: 10.1164/ajrccm.160.2.9812020

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  121 in total

1.  Sputum T lymphocytes in asthma, COPD and healthy subjects have the phenotype of activated intraepithelial T cells (CD69+ CD103+).

Authors:  M J Leckie; G R Jenkins; J Khan; S J Smith; C Walker; P J Barnes; T T Hansel
Journal:  Thorax       Date:  2003-01       Impact factor: 9.139

2.  Relationship between inflammatory cells and structural changes in the lungs of asymptomatic and never smokers: a biopsy study.

Authors:  K Amin; A Ekberg-Jansson; C-G Löfdahl; P Venge
Journal:  Thorax       Date:  2003-02       Impact factor: 9.139

3.  Neutrophilic infiltration within the airway smooth muscle in patients with COPD.

Authors:  S Baraldo; G Turato; C Badin; E Bazzan; B Beghé; R Zuin; F Calabrese; G Casoni; P Maestrelli; A Papi; L M Fabbri; M Saetta
Journal:  Thorax       Date:  2004-04       Impact factor: 9.139

4.  A novel technique to explore the functions of bronchial mucosal T cells in chronic obstructive pulmonary disease: application to cytotoxicity and cytokine immunoreactivity.

Authors:  M W Lethbridge; D M Kemeny; J C Ratoff; B J O'Connor; C M Hawrylowicz; C J Corrigan
Journal:  Clin Exp Immunol       Date:  2010-09       Impact factor: 4.330

Review 5.  Pathogenesis of chronic obstructive pulmonary disease.

Authors:  William MacNee
Journal:  Proc Am Thorac Soc       Date:  2005

Review 6.  Proteinases and oxidants as targets in the treatment of chronic obstructive pulmonary disease.

Authors:  Caroline A Owen
Journal:  Proc Am Thorac Soc       Date:  2005

Review 7.  Exploiting oxidative microenvironments in the body as triggers for drug delivery systems.

Authors:  Shivanjali Joshi-Barr; Caroline de Gracia Lux; Enas Mahmoud; Adah Almutairi
Journal:  Antioxid Redox Signal       Date:  2014-04-15       Impact factor: 8.401

Review 8.  New concepts in the pathobiology of chronic obstructive pulmonary disease.

Authors:  Victor Kim; Thomas J Rogers; Gerard J Criner
Journal:  Proc Am Thorac Soc       Date:  2008-05-01

Review 9.  Cardiac disease in chronic obstructive pulmonary disease.

Authors:  Jeremy A Falk; Steven Kadiev; Gerard J Criner; Steven M Scharf; Omar A Minai; Philip Diaz
Journal:  Proc Am Thorac Soc       Date:  2008-05-01

10.  Effects of fluticasone propionate on inflammatory cells in COPD: an ultrastructural examination of endobronchial biopsy tissue.

Authors:  M J Gizycki; K L Hattotuwa; N Barnes; P K Jeffery
Journal:  Thorax       Date:  2002-09       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.